The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes codifying the administration’s “most favored nation” agreements recently reached with certain drugmakers, where companies must offer Americans the lowest cost paid for the same medications in other countries. It also calls for sending subsidies directly to Americans instead of insurance companies and funding cost-sharing reductions to reduce premiums. The plan would also require health insurers to publish rate and coverage comparisons on their websites “in plain English — not industry jargon” for consumers. In addition, the plan calls for any health provider or insurer accepting Medicare or Medicaid to “prominently” post their pricing and fees. 

Headline
The Department of Labor July 22 released a proposed rule to modernize how group health plans deliver required disclosures. The proposal would create a safe…
Headline
The AHA provided comments July 21 to the Senate Committee on Health, Education, Labor and Pensions on price transparency, nursing workforce and rural…
Headline
The AHA provided comments to the House Energy and Commerce Committee July 21 on two price transparency bills the full committee…
Headline
The U.S. District Court for the District of Maryland July 16 enjoined eight provisions from the Centers for Medicare & Medicaid Services’ 2027 notice of…
Headline
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…
Headline
The AHA provided a statement to the House Ways and Means Committee for a markup July 15 on various pieces of health legislation. The AHA offered…